Cytosorbents Corporation (CTSO)
NASDAQ · Healthcare
Cytosorbents Corporation Operating Income 2011–2025
Cytosorbents Corporation annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cytosorbents Corporation operating income for the quarter ending March 31, 2026 was -3.0 M, a 21.71% decrease year-over-year.
- Cytosorbents Corporation operating income for the twelve months ending March 31, 2026 was -13.4 M, a 34.29% decrease year-over-year.
- Cytosorbents Corporation annual operating income for 2025 was -14.7 M, a 10.35% decrease from 2024.
- Cytosorbents Corporation annual operating income for 2024 was -16.5 M, a 48.50% decrease from 2023.
- Cytosorbents Corporation annual operating income for 2023 was -31.9 M, a 1.35% increase from 2022.
- Cytosorbents Corporation annual operating income for 2022 was -31.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cytosorbents Corporation Operating Income — FAQ
Cytosorbents Corporation (CTSO) operating income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Cytosorbents Corporation's operating income?
Cytosorbents Corporation (CTSO) reported operating income of -$15M for fiscal 2025.
Where can I see CTSO's operating income history?
The chart and table above show Cytosorbents Corporation's operating income by year and by quarter, including the growth rate.